The AI powerhouse is backing areas of AI it believes will deliver the most impact, from humanoid robotics to personal health to learning. We profile its key investments and acquisitions.
As concerns mount around the rise of counterfeit drugs, supply chain technologies such as IoT asset tracking, blockchain ledgers, and product & packaging authentication can provide pharma companies with more visibility and supply chain security.
Enterprises are seeing opportunities to deploy more cost-effective small models for tasks across industries like healthcare and finance. We dig into how adoption is picking up and the rising players in the space.
P.S. Our research team is looking for a senior associate editor. If you have strong feelings about the em dash and Oxford comma, check out the position here.
.png?upscale=true&width=1040&upscale=true&name=Insurance-earnings-calls-genAI%20(1).png)
